Active substancePancreatinPancreatin
Similar drugsTo uncover
  • Gastenorm forte
    pills inwards 
  • Gastenorm forte 10000
    pills inwards 
  • Creon® 10000
    capsules inwards 
  • Creon® 25000
    capsules inwards 
  • Creon® 40000
    capsules inwards 
  • Creon® Micro
    granules inwards 
  • Mezim® 20000
    pills inwards 
    BERLIN-PHARMA, CJSC     Russia
  • Mezim® forte
    pills inwards 
    BERLIN-PHARMA, CJSC     Russia
  • Mezim® forte 10000
    pills inwards 
    BERLIN-PHARMA, CJSC     Russia
  • Micrazim®
    capsules inwards 
    AVVA RUS, OJSC     Russia
  • Micrazim®
    capsules inwards 
    AVVA RUS, OJSC     Russia
  • Pangrol® 25000
    capsules inwards 
  • PanziKam
    pills inwards 
    CAMELIA NPP, LLC     Russia
  • Panzim® forte
    pills inwards 
    BRYNTSALOV-A, CJSC     Russia
  • Pancreatic
    pills inwards 
    TECHNOLOG, JSC     Ukraine
  • Pancreatin
    pills inwards 
    VALENTA PHARM, PAO     Russia
  • Pancreatin
    pills inwards 
  • Pancreatin
    pills inwards 
    AVEKSIMA, JSC     Russia
  • Pancreatin
    pills inwards 
    AVVA RUS, OJSC     Russia
  • Pancreatin
    pills inwards 
    FARMPROJECT, CJSC     Russia
  • Pancreatin
    pills inwards 
    BIOSINTEZ, PAO     Russia
  • Pancreatin forte
    pills inwards 
    BIOSINTEZ, PAO     Russia
  • Pancreatin-LekT
    pills inwards 
  • Penzital
    pills inwards 
  • Enzistal®-P
    pills inwards 
  • Hermitage®
    capsules inwards 
  • Dosage form: & nbspenteric coated tablets
    Composition:

    Active substance: Pancreatin with minimal enzymatic activity: amylase 7500 U FIP *, lipase 10,000 units FIP, proteases 375 U FIP

    Excipients: povidone K-30, sodium chloride, microcrystalline cellulose, crospovidone, sodium lauryl sulfate, silicon dioxide colloid, talc, magnesium stearate, opadrai white OY-IN-58903 (cellacate, triacetin, titanium dioxide, sorbitan oleate).

    * Units of the International Federation of Pharmaceuticals.

    Description:

    White or almost white, round, biconvex tablets, covered with enteric coating. A slightly rough surface may be observed.

    Pharmacotherapeutic group:Digestive enzyme agent
    ATX: & nbsp

    A.09.A.A   Enzyme preparations

    A.09.A.A.02   Pancreatin

    Pharmacodynamics:

    The drug compensates for the lack of exocrine function of the pancreas.

    The pancreatin enzymes of lipase, amylase and protease facilitate the digestion of fats, carbohydrates and proteins, which contributes to their fuller absorption in the small intestine.

    Indications:

    Insufficiency of the exocrine function of the pancreas (chronic pancreatitis, cystic fibrosis, etc.)

    Chronic inflammatory-dystrophic diseases of the stomach, intestines, liver, gall bladder. Conditions after resection or irradiation of these organs, accompanied by a violation of food digestion, flatulence, diarrhea (as part of combination therapy)

    To improve the digestion of food in patients with normal function of the gastrointestinal tract in the case of errors in nutrition, as well as violations of the masticatory function, long-term immobilization, a sedentary lifestyle.

    Preparation for X-ray and ultrasound examination of the abdominal organs.

    Contraindications:Hypersensitivity to the components of the drug, acute pancreatitis, exacerbation of chronic pancreatitis,children's age up to 3 years.
    Pregnancy and lactation:

    The safety of pancreatin in pregnancy is not well understood. The application is possible in cases where the expected benefit for the mother exceeds the potential risk to the fetus. During the lactation period, the use of pancreatin is not contraindicated.

    Dosing and Administration:

    The dose is determined individually depending on the degree of digestion disorders. Adults (in the absence of other prescriptions): 1-2 tablets with meals, without chewing and drinking with a sufficient amount of liquid.

    In children, the drug is used as directed by a doctor.

    Duration of treatment can vary from a single dose or several days (if the digestive process is disturbed due to inaccuracies in the diet) to several months or years (if necessary, permanent replacement therapy).

    Side effects:

    Allergic reactions (sneezing, lacrimation, skin rash). With prolonged use in high doses, it is possible to develop hyperuricosuria, an increase in the level of uric acid in the blood plasma. In case of cystic fibrosis, in case of exceeding the necessary dose of pancreatin, development of strictures (fibrous colonopathy) in the ileocecal region and in the ascending colon can be possible.

    When using pancreatin in high doses, children may experience perianal irritation and irritation of the oral mucosa.

    Overdose:

    Symptoms: hyperuricosuria, hyperuricemia. Children have constipation. Treatment: withdrawal of the drug, symptomatic therapy.

    Interaction:

    With the simultaneous use of pancreatin with iron preparations, it is possible to reduce absorption of the latter. The simultaneous use of antacid agents containing calcium carbonate and / or magnesium hydroxide, can lead to a decrease in the effectiveness of pancreatin.

    Form release / dosage:Tablets, covered with enteric coating.
    Packaging:For 10 tablets in PVC / aluminum blister. Two blisters together with instructions for use are placed in a pack of cardboard.
    Storage conditions:

    In the dark place at a temperature of no higher than 25 ° C.

    Keep out of the reach of children!

    Shelf life:

    3 years. Do not use after the expiry date printed on the package.

    Terms of leave from pharmacies:Without recipe
    Registration number:LSR-002122/08
    Date of registration:27.03.2008 / 29.12.2011
    Expiration Date:Unlimited
    The owner of the registration certificate:Roushan Pharma Co., Ltd.Roushan Pharma Co., Ltd. India
    Manufacturer: & nbsp
    Representation: & nbspRoushan Pharma Co., Ltd.Roushan Pharma Co., Ltd.
    Information update date: & nbsp15.03.2017
    Illustrated instructions
      Instructions
      Up